troglitazone has been researched along with endothelin-1 in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, M; Hashimoto, N; Hashimoto, Y; Isoo, N; Kimura, S; Maekawa, H; Satoh, H; Togo, M; Tsukamoto, K; Watanabe, T | 1 |
| Fujishima, M; Hirano, K; Hirano, M; Kanaide, H; Kawasaki, J; Nishimura, J | 1 |
| Bell, D; McDermott, BJ | 1 |
| Goto, K; Irukayama-Tomobe, Y; Miyauchi, T; Ogata, T; Sakai, S; Yamaguchi, I | 1 |
| Adachi, S; Akao, M; Ehara, N; Hasegawa, K; Iwai-Kanai, E; Kawamura, T; Kita, T; Morimoto, T; Ono, K | 1 |
| Bakris, GL; Sarafidis, PA | 1 |
| Li, YQ; Niu, XL; Wang, CX; Wang, SJ; Wei, J; Zhou, J | 1 |
| Anderson, HD; Huang, Y; Kopilas, MA; Netticadan, T; O'Hara, KA; Shao, Z; Yu, L; Zhang, H | 1 |
| Bales, ES; Doyle, AS; Houck, JA; Julian, CG; Lane, SL; Lorca, RA; Moore, LG | 1 |
1 review(s) available for troglitazone and endothelin-1
| Article | Year |
|---|---|
Protection of the kidney by thiazolidinediones: an assessment from bench to bedside.
Topics: Albuminuria; Animals; Blood Pressure; Chromans; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Endothelin-1; Humans; Hypoglycemic Agents; Kidney; Kidney Failure, Chronic; Pioglitazone; PPAR gamma; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors; Rosiglitazone; Thiazolidinediones; Time Factors; Troglitazone | 2006 |
8 other study(ies) available for troglitazone and endothelin-1
| Article | Year |
|---|---|
Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial function.
Topics: Animals; Cattle; Cells, Cultured; Chromans; Endothelin-1; Endothelium, Vascular; Hypoglycemic Agents; Insulin; Pioglitazone; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 1999 |
Troglitazone inhibits the capacitative Ca2+ entry in endothelial cells.
Topics: Adenosine Triphosphate; Animals; Aorta; Bradykinin; Calcium; Calcium Channel Blockers; Cells, Cultured; Chromans; Diltiazem; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Imidazoles; Swine; Thapsigargin; Thiazoles; Thiazolidinediones; Time Factors; Troglitazone; Vasodilator Agents | 1999 |
Troglitazone does not initiate hypertrophy but can sensitise cardiomyocytes to growth effects of serum.
Topics: Animals; Cattle; Cell Differentiation; Cell Survival; Chromans; Culture Media; Dose-Response Relationship, Drug; Drug Interactions; Endothelin-1; Fetal Blood; Glucose; Heart Ventricles; Hydrogen-Ion Concentration; Hypertrophy; Hypoglycemic Agents; Insulin; Insulin-Like Growth Factor I; Male; Myocardium; Norepinephrine; Phenylalanine; Protein Kinase C; Rats; Rats, Sprague-Dawley; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Peroxisome proliferator-activated receptor-gamma activators inhibit endothelin-1-related cardiac hypertrophy in rats.
Topics: Analysis of Variance; Animals; Cardiomegaly; Chromans; Endothelin-1; Endothelins; Male; Natriuretic Peptide, Brain; Pioglitazone; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stimulation, Chemical; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2002 |
Activators of PPARgamma antagonize protection of cardiac myocytes by endothelin-1.
Topics: Animals; Apoptosis; Cardiotonic Agents; Cells, Cultured; Chromans; DNA; DNA-Binding Proteins; Endothelin-1; Myocytes, Cardiac; NFATC Transcription Factors; Nuclear Proteins; Prostaglandin D2; Protein Binding; Proto-Oncogene Proteins c-bcl-2; Rats; Receptors, Cytoplasmic and Nuclear; Thiazolidinediones; Transcription Factors; Troglitazone | 2004 |
[Peroxisome proliferator-activated receptor activator troglitazone inhibits angiotensin II-stimulated secretion of vasoactive factors by endothelial cells].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Cell Line; Chromans; Dose-Response Relationship, Drug; Endothelial Cells; Endothelin-1; Gene Expression Regulation; Humans; Hypertension; Immunohistochemistry; Losartan; Nitric Oxide; PPAR gamma; Receptor, Angiotensin, Type 1; Thiazolidinediones; Troglitazone | 2007 |
Suppression of endothelin-1-induced cardiac myocyte hypertrophy by PPAR agonists: role of diacylglycerol kinase zeta.
Topics: Age Factors; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Chromans; Diacylglycerol Kinase; Endothelin-1; Fenofibrate; Hypoglycemic Agents; Hypolipidemic Agents; Myocytes, Cardiac; Peroxisome Proliferator-Activated Receptors; Rats; Rats, Sprague-Dawley; Signal Transduction; Thiazolidinediones; Troglitazone; Up-Regulation | 2011 |
Peroxisome proliferator-activated receptor gamma blunts endothelin-1-mediated contraction of the uterine artery in a murine model of high-altitude pregnancy.
Topics: Animals; Disease Models, Animal; Endothelin-1; Female; Fetal Growth Retardation; Hypoxia; Immunohistochemistry; Mice; Phenylephrine; Placenta; PPAR gamma; Pregnancy; Thiazolidinediones; Troglitazone; Uterine Artery | 2020 |